June 12 (UPI) --Doctors have traditionally relied on ultrasounds to examine men for prostate cancer, but the method can't pinpoint specific tumors, a new study says. When researchers combined this ...

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...

Prostate-specific membrane antigen, or PSMA, -targeted PET imaging for prostate cancer has been a breakthrough diagnosis tool in locating prostate cancer tumors for more precise treatment. The new ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

After doctors found cancer in Dr. Mark Samberg’s prostate last spring, the 70-year-old retired urologist prepared to have his prostate removed. He knew that the surgery would cure him, assuming the ...

DURHAM, N.C. -- A new multi-institutional study led by investigators at Duke University Medical Center indicates that a diagnostic scan may help localize recurrent prostate disease in men who have had ...

The LOCATE trial was a prospective, U.S., multicenter, open-label study investigating the impact of 18 F-fluciclovine PET/CT imaging on patient management of biochemically recurrent prostate cancer ...